17-17797478-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_030665.4(RAI1):​c.4530C>T​(p.Pro1510Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0613 in 1,613,206 control chromosomes in the GnomAD database, including 3,877 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 892 hom., cov: 33)
Exomes 𝑓: 0.058 ( 2985 hom. )

Consequence

RAI1
NM_030665.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.392

Publications

10 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-17797478-C-T is Benign according to our data. Variant chr17-17797478-C-T is described in ClinVar as Benign. ClinVar VariationId is 96192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.392 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.179 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAI1NM_030665.4 linkc.4530C>T p.Pro1510Pro synonymous_variant Exon 3 of 6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkc.4530C>T p.Pro1510Pro synonymous_variant Exon 3 of 6 1 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1

Frequencies

GnomAD3 genomes
AF:
0.0884
AC:
13439
AN:
152096
Hom.:
886
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.182
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0455
Gnomad ASJ
AF:
0.0277
Gnomad EAS
AF:
0.00482
Gnomad SAS
AF:
0.0240
Gnomad FIN
AF:
0.0741
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0588
Gnomad OTH
AF:
0.0789
GnomAD2 exomes
AF:
0.0553
AC:
13767
AN:
249068
AF XY:
0.0530
show subpopulations
Gnomad AFR exome
AF:
0.186
Gnomad AMR exome
AF:
0.0322
Gnomad ASJ exome
AF:
0.0286
Gnomad EAS exome
AF:
0.00290
Gnomad FIN exome
AF:
0.0781
Gnomad NFE exome
AF:
0.0585
Gnomad OTH exome
AF:
0.0532
GnomAD4 exome
AF:
0.0584
AC:
85385
AN:
1460992
Hom.:
2985
Cov.:
37
AF XY:
0.0568
AC XY:
41269
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.184
AC:
6138
AN:
33442
American (AMR)
AF:
0.0342
AC:
1525
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
672
AN:
26116
East Asian (EAS)
AF:
0.00194
AC:
77
AN:
39696
South Asian (SAS)
AF:
0.0268
AC:
2312
AN:
86236
European-Finnish (FIN)
AF:
0.0763
AC:
4042
AN:
52976
Middle Eastern (MID)
AF:
0.0468
AC:
270
AN:
5768
European-Non Finnish (NFE)
AF:
0.0600
AC:
66754
AN:
1111766
Other (OTH)
AF:
0.0596
AC:
3595
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
5508
11016
16524
22032
27540
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2500
5000
7500
10000
12500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0886
AC:
13483
AN:
152214
Hom.:
892
Cov.:
33
AF XY:
0.0878
AC XY:
6532
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.182
AC:
7561
AN:
41518
American (AMR)
AF:
0.0454
AC:
694
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
96
AN:
3470
East Asian (EAS)
AF:
0.00484
AC:
25
AN:
5170
South Asian (SAS)
AF:
0.0238
AC:
115
AN:
4824
European-Finnish (FIN)
AF:
0.0741
AC:
787
AN:
10620
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0587
AC:
3994
AN:
67996
Other (OTH)
AF:
0.0833
AC:
176
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
596
1192
1788
2384
2980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0671
Hom.:
314
Bravo
AF:
0.0906
Asia WGS
AF:
0.0540
AC:
189
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Dec 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Smith-Magenis syndrome Benign:1
May 03, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.78
DANN
Benign
0.35
PhyloP100
0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35686634; hg19: chr17-17700792; API